Regulation of apoptosis: Involvement of Bcl-2-related proteins

Reproduction Nutrition Development

Volumn 39, Issue 1, 1999, Pages 49-59

  Motyl, Tomasz ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Apoptosis; Bax; Bcl 2

Indexed keywords

ANIMALIA;

CALCIUM; CASPASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL; APOPTOSIS; CHEMISTRY; HOMEOSTASIS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; CALCIUM; CASPASES; HOMEOSTASIS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TISSUE DISTRIBUTION;

EID: 0032610587     PISSN: 09265287     EISSN: None     Source Type: Journal    
DOI: 10.1051/rnd:19990103     Document Type: Review

References (50)

1. Allen D.L., Linderman J.K., Roy R.R., Bigbec A.J., Grindeland R.E., Mukku V., Edgerton V.R., Apoptosis: a mechanism contributing to remodelling of skeletal muscle in response to hindlimb unweighting, Am. J. Physiol. 273 (1997) C579-C587.
2. Allen R.T., Cluck M.W., Agrawal D.K., Mechanisms controlling cellular suicide: role of Bcl-2 and caspases, Cell Mol. Life Sci. 54 (1998) 427-445.
3. Aritomi M., Kunishima N., Inohara N., Ishibashi Y., Ohta S., Morikawa K., Crystal structure of rat Bcl-xL, J. Biol. Chem. 272 (1997) 27886-27892.
4. Bauer J.J., Sesterhenn I.A., Mostofi F.K., Mcleod D.G., Srivastava S., Moul J.W., Elevated levels of apoptosis regulator proteins p53 and Bel-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer, J. Urol. 156 (1996) 1511-1516.
5. Chen C.Y., Faller D.V., Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis, J. Biol. Chem. 271 (1996) 2376-2379.
6. Chinnaiyan A.M., O'Rourke K., Lane Br., Dixit V.M., Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death, Science 275 (1997) 1122-1126.
7. Chou K.-C., Jones D., Heinrikson R.L., Prediction of the tertiary structure and substrate binding site of caspase-8, FEBS 419 (1997) 49-54.
8. Dominov J.A., Dunn J.J., Miller J.B., Bcl-2, apoptosis regulators and skeletal muscle stem cells, Proceedings of International Symposium on: Post-natal myogenesis: satellite cells in action!, Swissotel, Boston, USA, 13-16 August, 1998.
9. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature 391 (1998) 43-50.
10. Haldar S., Jena N., Croce C.M., Inactivation of Bcl-2 by phosphorylation, Proc. Natl. Acad. Sci. USA 92 (1995) 4507-4511.
11. Heermeier K., Benedict M., Li M., Furth P., Nanez G., Hennighausen I., Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells, Mech. Dev. 56 (1996) 197-207.
12. Hockenbery D.M., Zulter M., Hickey W., Nahm M., Korsmeyer S.J., Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death, Proc. Natl. Acad. Sci. USA 88 (1991) 6961-6965.
13. Hockenbery D.M., Oltvai Z.N., Yin X.-M., Milliman C.L., Korsmeyer S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell 75 (1993) 241-251.
14. Hsu Y.-T., Wolter K.G., Youle R.J., Cytosol-to-membrane redistribution of Bax and Bcl-xL during apoptosis, Biochemistry 94 (1997) 3668-3672.
15. Humphreys R.C., Krajewaka M., Krnacik S., Jaeger R., Weiher H., Krajewski S., Reed J.C., Rosen J.M., Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis, Development 122 (1996) 4013-4022.
16. Kerr J.F., Wyllie A.H., Currie A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer 26 (1972) 239-257.
17. Kidd V.J., Proteolytic activities that mediate apoptosis, Annu. Rev. Physiol. 60 (1998) 533-573.
18. Kitanaka C., Namiki T., Noguchi K., Mochizuki T., Kagaya S., Chi S., Hayashi A., Asai A., Tsujimoto Y., Kuchino Y., Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis, Oncogene 15 (1997) 1763-1772.
19. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.G., Reed J.C., Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2, Am. J. Pathol. 145 (1994) 1323-1336.
20. Kroemer G., The proto-oncogene Bcl-2 and its role in regulating apoptosis, Nat. Med. 3 (1997) 614-619.
21. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., Flavell R.A., Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta-converting enzyme, Science 267 (1995) 2000-2003.
22. Kurschner C., Morgan J.I., Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein, Mol. Brain Res. 37 (1996) 249-258.
23. 2+ fluxes, Med. Sci. 91 (1994) 6569-6573.
24. Lewis S., Bethell S.S., Patel S., Martinou J.-C., Antonsson B., Purification and biochemical properties of soluble recombinant human Bax, Prot. Express. Purif. 13 (1998) 120-126.
25. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X., Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell 86 (1996) 147-157.
26. McConkey D.J., Orrenius S., The role of calcium in the regulation of apoptosis. J. Leuk. Biol. 59 (1996) 775-783.
27. McDonnell T.J., Beham A., Sarkiss M., Andersen M.M., Lo P., Importance of Bcl-2 family in cell death regulation, Experientia 52 (1996) 1008-1017.
28. Merlo G.R., Cella N., Hynes N.F., Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells, Cell Growth Diff. 8 (1997) 251-260.
29. Mitamura S., Ikawa H., Mizuno N., Kaziro Y., Itoh H., Cytosolic nuclcase activated by caspase-3 and inhibited DFF-45, Biochem. Biophys. Res. Comm. 243 (1998) 480-484.
30. Muchmore S.W., Satter M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Changs B.S., Thompson C.B., Wong S.-I., Ng S.-C., Fesik S.W., X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature 381 (1996) 335-341.
31. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature 376 (1995) 37-43.
32. Otter I., Conus S., Ravn U., Rager M., Olivier R., Monney L., Fabbro D., Borner Ch., The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli, J. Biol. Chem. 273 (1998) 6110-6120.
33. Pan G., Humke E.W., Dixit V.M., Activation of caspases triggered by cytochrome c in vitro, FEBS Lett. 426 (1998) 151-154.
34. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G., Intraleukin-3-induced phosphorylation of BAD through the protein kinase Akt, Science 278 (1997) 687-689.
35. Ploszaj T., Motyl T., Orechowski A., Zimowska W., Wareski P., Skierski J., Zwierzchowski L., Antiapoptotic action of prolactin is associated with up-regulation of Bcl-2 and down-regulation of Bax in HC11 mouse mammary epithelial cells, Apoptosis 3 (1998) 1-10.
36. Reed C.J., Mechanisms of Bcl-2 family protein function and dysfunction in health and disease, Behring Inst. Mitt. 97 (1996) 72-100.
37. Schlesinger P.M., Gross A., Yin X.-M., Yamamoto K., Saito M., Waksman G., Korsmeyer S.J., Comparison of the ion channel characteristics of proapoptotic Bax and anti-apoptotic Bcl-2, Proc. Natl. Acad. Sci. USA 94 (1997) 11357-11362.
38. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsuda H., Tsujimoto Y., Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux, Proc. Natl. Acad. Sci. USA 95 (1998) 1455-1459.
39. Tsujimoto Y., Croce C.M., Analysis of the structure, transcripts, and protein products of Bcl-2, the gene involved in human follicular lymphoma, Proc. Natl. Acad. Sci. 83 (1986) 5214-5218.
40. Tsujimoto Y., Cossmann J., Jaffe E., Croce C., Involvement of the Bcl-2 gene in human follicular lymphoma, Science 228 (1985) 1440-1443.
41. Vaux D.L., CED-4 - the third horseman of apoptosis, Cell 90 (1997) 389-390.
42. Vermes I., Haanen C., Richel D.J., Schaafsma M.R., Kalsbeek-Batenburg E., Reutelingsperger C.P., Apoptosis and secondary necrosis of lymphocytes in culture, Acta Haematol. 98 (1997) 8-13.
43. Villa P., Kaufmann S.H., Earnshaw W.C., Caspases and caspase inhibitors, Trends Biochem. Sci. 22 (1997) 388-393.
44. Wareski P., Motyl T., Ploszaj T., Janczewska S., Orzechowski A., Ryniewicz Z., Regulation of bax expression in mammary gland remodelling, Proceedings of International Symposium on: Development of adaptations in the gastrointestinal tract and in the whole body in growing animals regarding food utilization and health, Paris, France, 23-24 June, 1998.
45. Wolter K.G., Hsu Y.-T., Smith C.L., Nechushtan A., Xi X.-G., Youle R.J., Movement of Bax from the cytosol to mitochondria during apoptosis, J. Cell Biol. 139 (1997) 1281-1292.
46. Yamaguchi A., Maehara M., Goi T., Katayama K., Hirose K., Nakagawara G., Bcl-2 protein expression in breast cancer and its relationship to prognosis, Int. J. Oncol. 10 (1997) 581-584.
47. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., Kroemer G., Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis, J. Bioenerg. Biomembr. 29 (1997) 185-193.
48. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.L., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL, Cell 87 (1996) 619-628.
49. Zimowska W., Motyl T., Skierski J., Balasinska B., Ploszaj T., Orzechowski A., Filipecki M., Apoptosis and Bcl-2 protein changes in L1210 leukaemic cells exposed to oxidative stress, Apoptosis 2 (1997) 529-539.
50. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X., Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3, Cell 90 (1997) 405-413.